STOCK TITAN

Bio Green Med (BGMS) sets $0.15 quarterly dividend on preferred

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Bio Green Med Solution, Inc. announced that its Board of Directors declared a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock. The dividend will be paid on May 1, 2026 to preferred stockholders of record at the close of business on April 23, 2026.

Positive

  • None.

Negative

  • None.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Quarterly dividend per share $0.15 per share Declared on 6% Convertible Exchangeable Preferred Stock
Dividend rate 6% Coupon rate on Convertible Exchangeable Preferred Stock
Dividend payment date May 1, 2026 Payable date for the $0.15 per share dividend
Record date April 23, 2026 Stockholders of record eligible for dividend
6% Convertible Exchangeable Preferred Stock financial
"a quarterly cash dividend of $0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock"
quarterly cash dividend financial
"declared a quarterly cash dividend of $0.15 per share"
A quarterly cash dividend is a payment made by a company to its shareholders four times a year, usually based on its profits. It is like a regular bonus or reward for owning the company's stock, providing shareholders with income. Many investors see these payments as a sign of the company's stability and its ability to generate consistent profits.
stockholders of record financial
"to Preferred Stock stockholders of record as of the close of business on April 23, 2026"
Stockholders of record are the people or entities whose names appear on a company's official shareholder list on a specific cutoff date set by the company or its transfer agent; only those listed are entitled to receive dividends, vote at shareholder meetings, or participate in other corporate actions. Think of it like a guest list for an event: being on the list on the set day determines who gets the benefits and rights, so investors must own shares before the cutoff to qualify.
false 0001130166 0001130166 2026-04-13 2026-04-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

April 13, 2026

Date of Report (date of earliest event reported)

 

 

 

Bio Green Med Solution, Inc.

(Exact name of Registrant as specified in its charter)

 

Delaware   0-50626   91-1707622

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

Level 10, Tower 11, Avenue 5,

No. 8 Jalan Kerinchi, Kuala Lumpur, Malaysia 59200

(Address of principal executive offices) (Zip code)

 

(908) 955-0526

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   BGMS   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 8.01 Other Events.

 

On April 13, 2026, the Board of Directors of Bio Green Med Solution, Inc. (the “Company”) declared a quarterly cash dividend of $0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock (the “Preferred Stock”). The dividend is payable on May 1, 2026, to Preferred Stock stockholders of record as of the close of business on April 23, 2026.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: April 13, 2026 Bio Green Med Solution, Inc.
     
  By: /s/ Datuk Dr. Doris Wong Sing Ee
  Name: Datuk Dr. Doris Wong Sing Ee
  Title: Chief Executive Officer and Executive Director

 

 

 

FAQ

What dividend did Bio Green Med Solution (BGMS) declare on its preferred stock?

Bio Green Med Solution declared a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock. This payment reflects the regular income feature attached to this preferred security class.

When will Bio Green Med Solution (BGMS) pay the declared preferred dividend?

The declared dividend will be paid on May 1, 2026. Holders of the company’s 6% Convertible Exchangeable Preferred Stock as of the specified record date will receive the $0.15 per share cash payment on that date.

What is the record date for Bio Green Med Solution (BGMS) preferred dividend?

The record date for the dividend is April 23, 2026. Investors holding the 6% Convertible Exchangeable Preferred Stock at the close of business on that day will be eligible to receive the $0.15 per share cash dividend.

Which security of Bio Green Med Solution (BGMS) receives the new dividend?

The dividend applies to the company’s 6% Convertible Exchangeable Preferred Stock. Common stock is listed on the Nasdaq Capital Market under the BGMS symbol, but this specific dividend is declared only on the preferred stock class.

How often does Bio Green Med Solution (BGMS) pay this preferred stock dividend?

The payment described is a quarterly cash dividend of $0.15 per share on the 6% Convertible Exchangeable Preferred Stock. Describing it as quarterly indicates it is scheduled to be paid four times per year on this preferred class.

Filing Exhibits & Attachments

3 documents